Who has invested in Rapt Therapeutics?

No investors are named on the public record for Rapt Therapeutics yet.

Rapt Therapeutics Funding: $125M Raised, Series B (2022)

Rapt Therapeutics funding overview

Rapt Therapeutics is based in Palo Alto, California. Rapt Therapeutics has raised $125M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2022. The round record for Rapt Therapeutics runs through 2022; nothing later has been disclosed.

Rapt Therapeutics at a glance

Total raised: $125M
Latest round: Series B
Latest round date: January 2022
Headquarters: Palo Alto, California

Frequently asked about Rapt Therapeutics funding

How much has Rapt Therapeutics raised?: Rapt Therapeutics has raised $125M in total disclosed funding across the rounds on record.
Who has invested in Rapt Therapeutics?: No investors are named on the public record for Rapt Therapeutics yet.
What was the latest Rapt Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2022.
Where is Rapt Therapeutics based?: Rapt Therapeutics is based in Palo Alto, California.
When did Rapt Therapeutics last raise?: The last disclosed Rapt Therapeutics round closed in January 2022 at Series B.

Rapt Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Palo Alto below to benchmark round size and investor mix.

Rapt Therapeutics Funding: $125M Raised, Series B (2022)

Rapt Therapeutics funding overview

Rapt Therapeutics at a glance

Frequently asked about Rapt Therapeutics funding

Companies related to Rapt Therapeutics (18)

Browse related funding lists (5)